Skip to main content

Senate bill · S. 3716 (119th Congress)

RARE Act

U.S. Senate

Latest action Jan 28, 2026

Sponsor: Tammy Baldwin (U.S. Senator for Wisconsin, Democratic)

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data

Summary

Would narrow the seven-year market exclusivity granted to drugs approved for rare diseases so that it applies only to the specific approved use or indication, rather than to the rare disease or condition as a whole.

AI summary. Not an official summary. How we handle summaries

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

Senate Committee on Health, Education, Labor, and Pensions · U.S. Senate

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

As identified by Congress.gov.

Full history

  1. Jan 28, 2026

    Introduced

    Introduced in U.S. Senate

    U.S. Senate

  2. Jan 28, 2026

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  3. Jan 28, 2026

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  4. Jan 28, 2026

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Read the record